ARGX:NASDAQ
argenx SE - ADR
$912.87
arrow_downward
-0.69%(-6.34) 1D
$912.87
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 5, 4:00:02 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
$920.82
High
$923.31
Low
$903.50
Mkt. cap
56.95B
Avg. vol.
257.81K
Volume
322.12K
P/E ratio
34.68
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.45
Shares outstanding
62.56M
No. of employees
2K
Open
$920.82
High
$923.31
Low
$903.50
Mkt. cap
56.95B
Avg. vol.
257.81K
Volume
322.12K
P/E ratio
34.68
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.45
Shares outstanding
62.56M
No. of employees
2K
News stories
From web sources and news partners
AD HOC NEWS
·
1 hour ago
Argenx stock gets fresh VYVGART data before Q3 results
AD HOC NEWS
·
6 hours ago
argenx stock after-hours at EUR 810.80: minus 0.69 percent versus prior close
Zacks
·
7 hours ago
BMY or ARGX: Which Is the Better Value Stock Right Now?
Yahoo Finance UK
·
8 hours ago
BMY or ARGX: Which Is the Better Value Stock Right Now?
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR